ArticleCase reports in oncological medicine2013
Mucoepidermoid carcinoma of the lung: a case report and literature review.
Article in Case reports in oncological medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 33 citations in OpenAlex.
- Primary Pulmonary Endobronchial Mucoepidermoid Carcinoma Treated With Sleeve Resection in a 23-Year-Old Woman: Case Report.Respirology case reports · 2025Article
- Case Report: Mucoepidermoid carcinoma of the lung, a challenging diagnosis of an unusual case.Frontiers in oncology · 2025Article
- Mucoepidermoid carcinoma of the lung with hemoptysis as initial symptom: A case report.World journal of clinical cases · 2023Article
- Molecular Mechanisms of Carcinogenesis in Pediatric Airways Tumors.International journal of molecular sciences · 2023Review
- Article
- Pulmonary mucoepidermoid lung carcinoma in pediatric confused with asthma.Respiratory medicine case reports · 2021Article
- Curious case of primary pulmonary mucoepidermoid carcinoma.Journal of family medicine and primary care · 2019Article
- Rare cause of lung atelectasis in a young woman.BMJ case reports · 2019Article
- Mucoepidermoid Carcinomas Presented as Lobar Pneumonia.Chinese medical journal · 2018Article
- Interventional Bronchoscopic Therapy in Adult Patients with Tracheobronchial Mucoepidermoid Carcinoma.Chinese medical journal · 2017Article
- Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.Virchows Archiv : an international journal of pathology · 2017Review
- Pulmonary mucoepidermoid carcinoma in Chinese population: a clinicopathological and radiological analysis.International journal of clinical and experimental pathology · 2015Article
- Clinicopathological analysis of pulmonary mucoepidermoid carcinoma.World journal of surgical oncology · 2014Article
- Left lower lobectomy for uncommon endobronchial mucoepidermoid carcinoma in a 15-year-old male.Journal of postgraduate medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction. Mucoepidermoid carcinoma (MEC) of the lung is a rare form of lung cancer that is classified into low grade and high grade based on histological features. Surgical resection is the primary treatment for low-grade MEC with excellent outcomes, while high-grade MEC is a more aggressive form of malignancy. Clinical Case. We report a case of a 46-year-old woman who presented with dyspnea on exertion. Imaging studies revealed a mass involving the right upper lobe bronchus. Bronchoscopy, surgical resection, and pathological examination revealed a low-grade MEC with tumor-free margins. No adjuvant treatment was given. Discussion. Primary pulmonary MEC is a rare type of lung cancer with only few reported cases. This patient illustrates a typical presentation for low-grade MEC wherein surgical resection is considered curative. In contrast, high-grade MEC is a more aggressive malignancy with a poorer outcome. The role of targeted therapy directed against EGFR or a novel CRTC1-MAML2 fusion protein expressed in some high-grade tumors is yet to be determined.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.